Table: Daito -2023/24 group results

Daito Pharmaceutical

12/07/2024 07:00

Jul 12 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2024    May 31, 2023   May 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             46.90           45.10          49.00                 
                 (+4.0 pct)      (+3.8 pct)     (+4.5 pct)               
  Operating          3.89            5.21           3.50                 
                 (-25.2 pct)     (-20.5 pct)    (-10.1 pct)              
  Recurring          3.92            5.17           3.50                 
                 (-24.1 pct)     (-23.2 pct)    (-10.8 pct)              
  Net
  Net                3.30            3.60           2.30                 
                 (-8.5 pct)      (-22.9 pct)    (-30.2 pct)              
  EPS            210.00 yen      227.63 yen     150.39 yen               
  EPS Diluted                    227.42 yen                              
  Ann Div         60.00 yen       60.00 yen      70.00 yen               
  -Q2 Div         30.00 yen       30.00 yen      35.00 yen               
  -Q4 Div         30.00 yen       30.00 yen      35.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T